144 related articles for article (PubMed ID: 3241329)
1. [Clinical studies on S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory tract infections].
Aonuma S; Oizumi K; Watanabe A; Tokue Y; Honda Y; Ono R; Kitamura N; Konno K; Satoh K
Jpn J Antibiot; 1988 Sep; 41(9):1309-12. PubMed ID: 3241329
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory airway infections].
Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Numata H; Takahashi K; Yamaki I; Ishii S
Jpn J Antibiot; 1988 Sep; 41(9):1325-33. PubMed ID: 3241332
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
Tanimoto H; Nakamori Y
Jpn J Antibiot; 1988 Sep; 41(9):1319-24. PubMed ID: 3241331
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
Hiraga Y; Omichi M; Sasaoka S
Jpn J Antibiot; 1988 Sep; 41(9):1304-8. PubMed ID: 3241328
[TBL] [Abstract][Full Text] [Related]
5. [Clinical examination of S 6472 (sustained release preparations of cefaclor on chronic respiratory tract infection].
Hayashi I; Ohnuma K
Jpn J Antibiot; 1988 Sep; 41(9):1313-8. PubMed ID: 3241330
[TBL] [Abstract][Full Text] [Related]
6. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections].
Spath P
Wien Med Wochenschr; 1983 Jan; 133(1):27-30. PubMed ID: 6837048
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies of S6472 in otorhinolaryngologic infections].
Baba S; Kinoshita H; Mori Y; Suzuki K; Ohyama M; Katsuta K; Furuta S; Ohno I; Noboru T; Yamamoto M
Jpn J Antibiot; 1985 Jul; 38(7):1750-60. PubMed ID: 4068219
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies of cefaclor for respiratory tract infections].
Hiraga Y; Kikuchi K; Yamamoto A
Jpn J Antibiot; 1984 Apr; 37(4):581-8. PubMed ID: 6471379
[TBL] [Abstract][Full Text] [Related]
10. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
Sakai K; Fujimoto M; Ueda T; Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Doi S
Jpn J Antibiot; 1985 Oct; 38(10):2716-34. PubMed ID: 3908726
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of lower respiratory tract infections with cefuroxime-axetil. Comparison with cefaclor].
Pariente R; Rochemaure J; Murciano D; Brechot JM; Pappo M
Therapie; 1988; 43 Suppl 4():361-4. PubMed ID: 3222777
[No Abstract] [Full Text] [Related]
13. [Fundamental and clinical studies of a sustained release preparation of cefaclor in the surgical field].
Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Ito T; Tanabe M; Fukuhara A; Sakakibara O
Jpn J Antibiot; 1985 Mar; 38(3):859-68. PubMed ID: 3897613
[TBL] [Abstract][Full Text] [Related]
14. [Effect of cefaclor in urinary tract infections (2)].
Kajikawa H; Hosokawa S; Kameoka H; Nishimoto N; Miyoshi S; Iwao N; Mizutani S
Jpn J Antibiot; 1984 Aug; 37(8):1453-69. PubMed ID: 6502932
[TBL] [Abstract][Full Text] [Related]
15. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
[TBL] [Abstract][Full Text] [Related]
16. [Fundamental and clinical studies of S 6472 (sustained release preparation of cefaclor) in the pediatric field].
Sugita M; Toyonaga Y; Nakamura H; Kurosu Y; Hori M
Jpn J Antibiot; 1985 Sep; 38(9):2444-52. PubMed ID: 3908736
[TBL] [Abstract][Full Text] [Related]
17. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
Leveque B; Lambert-Zechovsky N; Cathlin C
Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
[No Abstract] [Full Text] [Related]
18. Treatment of acute bronchitis and pneumonia with cefaclor.
Mattson K; Renkonen OV; Laitinen L; Nikander-Hurme R
Postgrad Med J; 1979; 55 Suppl 4():59-61. PubMed ID: 398482
[TBL] [Abstract][Full Text] [Related]
19. [Studies of sustained release cephalexin (S-6437) in pediatrics (author's transl)].
Saito K; Ubukata K; Konno M
Jpn J Antibiot; 1977 Sep; 30(9):672-6. PubMed ID: 916187
[TBL] [Abstract][Full Text] [Related]
20. Cefaclor revisited.
Meyers BR
Clin Ther; 2000 Feb; 22(2):154-66. PubMed ID: 10743978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
